Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 14/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | PLEC | Q15149 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 12/20 | 0.50 |
| ▸ | CA2 | P00918 | 12/20 | 0.50 |
| ▸ | CA12 | O43570 | 6/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.48 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL799734 | 1.00 | USP2 (0.62) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL29399313 | 0.97 | USP2 (0.58) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL29415506 | 0.94 | USP2 (0.56) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL2054802 | 0.94 | USP2 (0.56) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL3728723 | 0.93 | USP2 (0.57) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL12238065 | 0.89 | USP2 (0.47) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL31327372 | 0.88 | USP2 (0.50) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL20912026 | 0.86 | USP2 (0.57) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL29352834 | 0.86 | USP2 (0.56) | USP2L3MBTL1MEN1POLBKMT2A | |
| SCHEMBL6693395 | 0.86 | USP2 (0.56) | USP2L3MBTL1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4378534-A2 | CYCLOTIDES AS IMMUNOSUPPRESSIVE AGENTS | Medizinische Universität Wien (AT) | 2024-06-05 | — | — | EP | disclosed |
| EP-3431095-B1 | CYCLOTIDES AS IMMUNOSUPPRESSIVE AGENTS | UNIV WIEN MED (AT) | 2023-11-01 | — | — | EP | disclosed |
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-22 | — | — | US | disclosed |
| CN-113616807-B | Mitochondrion-targeted polypeptide and preparation method and application thereof | 中山大学 | 2023-07-21 | — | — | CN | disclosed |
| US-20230041271-A1 | Mitochondria-Targeted Polypeptide, Preparation Method thereof, and Use thereof | SUN YAT-SEN UNIVERSITY (CN) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | ABCB4, ABCB1, ZFR | USP2 1247/4885L3MBTL1 354/4885MEN1 2357/4885 |
| US-20230041271-A1 | Mitochondria-Targeted Polypeptide, Preparation Method thereof, and Use thereof | MTPN, TIMM13, TIMM10 | USP2 3871/4885L3MBTL1 1637/4885MEN1 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.